EQS-Adhoc: Marinomed Biotech AG begins contract negotiations for the sale of the Carragelose portfolio
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Strategic Company Decision Marinomed Biotech AG begins contract negotiations for the sale of the Carragelose portfolio 11-Oct-2024 / 12:48 CET/CEST Disclosure of an…